Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipramine and Lomustine in Recurrent Glioblastoma
NCT04863950Phase 2Recruiting
- Sponsor
- UT Health San Antonio
- Start
- May 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imipramine in glioblastoma (GBM), sponsored by UT Health San Antonio. Started May 2022; status: recruiting.
02
Drugs
imipramine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04863950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04863950.